Mendoza C.B.
Prognostic significance of tumor cells in the bone marrow // Surg.
Gynecol. Obstet. — 1969. — P. 483 488.
Meyerson B.A.
The role of neurosugery un the treatment of cancer pain // Acta
Anaesthesiologica Scandinavia. — 1982. — V. 74. — P. 109 113.
McCloskey E.V., Spector T.D., Eyres K.S., Fern D.E., O
,
Rourke N., Vasikaran S.,
Kanis J.A.
The assessment of vertebral deformity – a method for use in population studies
and clinical trials // Osteoporosis Int. — 1993. — V. 3. — P. 138 147.
McCormack R.R., Glass D.B., Lane J.M.
Functional cast bracing of metastatic
humeral shaft lesion // Orthop. Trans. — 1985. — V.9 — P. 50 51.
McDonnell G.D., Dunstan C.R., Evans R.A.
è ñîàâò. Quantitative bone histology in
the hypercalcaemia of malignant disease // J. Clin. Endocrinol. Metab. — 1982. — V. 55. —
P. 1066 1072.
McEwan A.J
. Unsealed source therapy of painful bone metastases: an update //
Semin. Nucl. Med.. — 1997. — V. 27(2). — P. 165 182.
Mc Neil B.I.
Radionuclide for the bone scan S, in selected metastases and primary
bone tumors // Sem. Sin. Nucl. Med. — 1978. — V. 8. — P. 336 346.
McNeil B.J., Pace P.D., Gray E.B., Adelstein S.J., Wilson R.E.
Preoperative and fol
low up bone scans in patients with primary carcinoma of the breast // Surg. Gynecol.
Obstet. — 1978. — V. 147. — P.745 748.
Meijer W.G., van der Veer E., Willemse P.H.
Biochemical parameters of bone metab
olism in bone metastases of solid tumors (review) // Oncol. Rep. — 1998. — V. 5(1). —
P. 5 21.
Mende U.
Indications and possibilities of ultrasound diagnosis in skeletal metastases
// Radiologe. — 1995. — V. 35(1). — P. 28 38.
Merkle E., Bahr J., Henke A., Buhner M., Martus P.
Immunocytochemical detection
of tumor cells in bone marrow as a prognostic factor in breast carcinoma // Geburtshilfe
Frauenheilkd. — 1994. — V. — 54(12). — P. 662 669.
Mertens W.C., Filipczak L.A., Ben+Josef E., Davis L.P., Porter A.T.
Systemic bone
seeking radionuclides for palliation of painful osseous metastases: current concepts // CA
Cancer J. Clin. — 1998 V. 48(6). — P. 361 374.
Miller A.
Radiophosphorous (P32) treatment in carcinoma of the breast and
prostate. A report of 39 cases // J. Amer. Osteopath. A.S.S — 1974. — P.217.
Minton J.
The response of breast cancer patients with bone pain to L DOPA //
Cancer. — 1974. — V. 33. — P. 358 363.
Minton M.J., Knight R.K., Rubens R.D., Hayward J.L
. Corticosteroids for elderty
patients with breast cancer // Cancer. — 1981. — V. 48. — P. 883 887.
Miser A.W., Narang P.K., Dothage J.A.,
è ñîàâò. Transdermal fentanyl for pain con
trol in patient with cancer // Pain. — 1989. — V. 37(1). — P. 15 21.
Miura H., Yamamoto I., Takada M., Kigami Y., Ohta T., Yuu I., Hamanaka Y.,
Matsushita R., Morita R.
Diagnostic validity of bo ne metabolic markers for bone metasta
sis // Endocr. J. — 1997. — V. 44(5). — P. 751 757.
Moneypenny I.J., Grieve R.J., Howell A., Morrison J.M.
The value of serial bone
scanning in operable breast cancer // Br. J. Surg. — 1984. — V. 71. — P. 466 468.
Moon D.H., Maddahi J., Silverman D.H., Glaspy J.A., Phelps M.E., Hoh C.K
.
Accuracy of whole body fluorine 18 FDG PET for the detection of recurrent or metasta
tic breast carcinoma // J. Nucl. Med. — 1998. — V. 39(3). — P. 431 435.
Morita K., Ito Y.
Radiation therapy of osseus metastasis // Gan. No. Rinsho. —
1988. — V. 34(9). — P. 1130 1138.
238
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
